Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 122, Issue 2, Pages 321-332
Publisher
Wiley
Online
2012-04-12
DOI
10.1111/j.1471-4159.2012.07754.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of action of intravenous immunoglobulins
- (2011) Anne Baerenwaldt et al. Expert Review of Clinical Immunology
- Pathophysiology, treatment, and animal and cellular models of human ischemic stroke
- (2011) Trent M Woodruff et al. Molecular Neurodegeneration
- Evidence that -Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the Nuclear Factor- B-Bcl-2-Interacting Mediator of Cell Death Pathway in Ischemic Stroke
- (2011) T. V. Arumugam et al. MOLECULAR PHARMACOLOGY
- Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
- (2011) Robert M. Anthony et al. NATURE
- Inhibition of JNK phosphorylation reverses memory deficit induced by β-amyloid (1–42) associated with decrease of apoptotic factors
- (2010) Mahmoudreza Ramin et al. BEHAVIOURAL BRAIN RESEARCH
- The other side of immunoglobulin G: suppressor of inflammation
- (2010) S. Aschermann et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
- (2010) Johanna Magga et al. Journal of Neuroinflammation
- N-stearoyltyrosine protects primary neurons from Aβ-induced apoptosis through modulating mitogen-activated protein kinase activity
- (2010) Z.H. Yang et al. NEUROSCIENCE
- Intravenous immunoglobulins - understanding properties and mechanisms
- (2009) A. Durandy et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders
- (2009) Mark P. Mattson EXPERIMENTAL GERONTOLOGY
- Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science
- (2009) Beatrix Kotlan et al. Immunotherapy
- Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway
- (2009) Vanja Vukic et al. NEUROBIOLOGY OF DISEASE
- IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders
- (2009) H. Fillit et al. NEUROLOGY
- Targeting p38 MAPK pathway for the treatment of Alzheimer's disease
- (2009) Lenka Munoz et al. NEUROPHARMACOLOGY
- Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3β is required for tau aggregation
- (2008) Naruhiko Sahara et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal
- (2008) Sung-Chun Tang et al. EXPERIMENTAL NEUROLOGY
- Ambivalent effect of immunoglobulins on the complement system: Activation versus inhibition
- (2008) Milan Basta MOLECULAR IMMUNOLOGY
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Neuroprotection in stroke by complement inhibition and immunoglobulin therapy
- (2008) T.V. Arumugam et al. NEUROSCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now